REMD Biotherapeutics Competitors and Similar CompaniesClear all
REMD Biotherapeutics's competitors and similar companies include Ainos, Alteogen, Zura Bio and Carmot Therapeutics.
 REMD Biotherapeutics REMD Biotherapeutics is a biopharmaceutical company focusing on bio-medicines to treat cancer, diabetes, and other diseases. |  Ainos Ainos (formerly known as Amarillo Biosciences) is a healthcare company that specializes in the development of novel biopharmaceuticals, medical treatments, and specialty consumer products. |  Alteogen Alteogen ((주)알테오젠) is a biopharmaceutical company that develops therapeutic proteins, antibody-drug conjugates, (ADC), and monoclonal antibody biosimilars. |  Zura Bio Zura Bio is company a clinical-stage biotechnology company advancing immunology assets into development programs. |  Carmot Therapeutics Carmot Therapeutics is a clinical-stage biotechnology company focused on the discovery of disease-modifying therapies in metabolic disease and cancer. | |
Founding Date | Founding Date 2011 | Founding Date 1984 | Founding Date 2008 | Founding Date 2022 | Founding Date 2008 |
Type | Type Private | Type Public | Type Public | Type Public | Type Subsidiary |
Tags | |||||
Locations | Locations Camarillo, US HQ Beijing, CN | Locations Amarillo, US HQ Taipei, TW | Locations Daejeon, KR HQ Seoul, KR | Locations San Diego, US HQ Altrincham, GB | Locations Berkeley, US HQ |
Employees | Employees 6 | Employees 4326% increase | Employees 155 | Employees N/A | Employees 109% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) 4.4 m | Valuation ($) N/A | Valuation ($) 285.7 m | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $124.2k (FY, 2025) | Revenue (est.) ₩215.9b (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods $21.2k (FY, 2025) | Cost of goods ₩48.3b (FY, 2025) | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit $102.9k (FY, 2025) | Gross profit ₩212.7b (FY, 2025) | Gross profit N/A | Gross profit N/A |
Net income | Net income N/A | Net income ($14.8m) (FY, 2025) | Net income ₩145.2b (FY, 2025) | Net income ($68.7m) (FY, 2025) | Net income ($38.8m) (FY, 2022) |
For sources of this data, please see the company profile
View Company Profiles
Ainos
HQ
Amarillo, US
Employees
43↑ 26% increase
Ainos (formerly known as Amarillo Biosciences) is a healthcare company that specializes in the development of novel biopharmaceuticals, medical treatments, and specialty consumer products.
View companyAlteogen
HQ
Daejeon, KR
Employees
155
Alteogen ((주)알테오젠) is a biopharmaceutical company that develops therapeutic proteins, antibody-drug conjugates, (ADC), and monoclonal antibody biosimilars.
View companyZura Bio
HQ
San Diego, US
Zura Bio is company a clinical-stage biotechnology company advancing immunology assets into development programs.
View companyCarmot Therapeutics
HQ
Berkeley, US
Carmot Therapeutics is a clinical-stage biotechnology company focused on the discovery of disease-modifying therapies in metabolic disease and cancer.
View company